Introduction
============

Prescribing errors are defined as prescribing decision or mistakes in the prescription writing process that result in unintentional significant reduction in the probability of timely and effective treatment or an increase in the risk of harm. Prescribing errors are a common cause for preventable medication errors and adverse drug events in primary care.[@B1] Frequent occurring prescription errors include incorrect selection of medication for the patient including the dose, quantity, indication, or the prescribing a contraindicated medication.[@B2]

Community pharmacists have an important role in detecting, preventing, and solving prescription problems, which if left unresolved, may pose a risk of harming the patient.[@B3] Pharmacists intervene to eliminate or minimize these risks, often by contacting the prescriber with suggestions to change the medication.[@B4] In studies that have judged the clinical importance of pharmacists\' actions, it was found that their actions were clinically relevant and approved by the prescribers in most cases.[@B5],[@B6],[@B7],[@B8]

However, the recorded rates of prescription problems at pharmacies are composed of prescription error rates, detection rates, and actions taken, as well as recording rates. Detection and action rates by pharmacists are influenced by pharmacy size, location, organization of work and work load of the pharmacy[@B9] and available information concerning patient and prescribed medication.[@B10]

Prescription error rates may vary with prescribers, licensing examination scores, medical speciality, experience, practice group structure and culture, and the number of doctors involved in prescribing to the patient. Error rates may also vary with the design of the prescription form and how the prescription is generated (handwritten prescription, prescriptions produced in the electronic medical record and electronically transmitted prescriptions to pharmacies).[@B11],[@B12],[@B13],[@B14],[@B15] Error rates are higher with handwritten prescriptions, where ambiguous instructions and interpretation errors and administrative errors, such as missing prescriber or patient data, may constitute a large part of the recorded prescription problems.[@B11]

Pharmacists\' detection, recording, and action rates of prescription errors are influenced by pharmacy size, location, organization, workload, available information (such as presence on the prescription of indication or intended use), access to patient record or patient medication profile, attendance of the patient or a representative at the pharmacy to have the prescription dispensed, and the individual pharmacists\' education and training.

Recording rates may vary with recording method and appropriateness and feasibility of recording instruments used. Different instruments have been used in different studies, but few of them have been evaluated. Some may have been developed for classification of prescription problems in the context of handwritten prescriptions, others for use in situ in a specific local context or study. Furthermore, in a context where mainly printouts of prescriptions in the electronic medical record and electronically transmitted prescriptions to pharmacies are used, previous classifications may be obsolete, and the error pattern may have changed. Errors commonly encountered with handwritten prescriptions may have resolved but new clinically significant errors such as incorrect drug selection, may have been introduced.[@B16],[@B17]

Estonia, Norway and Sweden differ in their organization of health care and the community pharmacy sector.[@B18],[@B19],[@B20] Detailed information concerning operation of community pharmacies and drug prescribing systems is presented in [Table 1](#T1){ref-type="table"}.

###### 

Operation of community pharmacies and prescribing systems of medicinal products in Estonia, Norway and Sweden

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Country                                                      Estonia                                                                   Norway                                                                                                     Sweden (at the time of the study)
  ------------------------------------------------------------ ------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------
  Population (01.01.2011)                                      1 340 100                                                                 4 920 305                                                                                                  9 428 100

  Number of community pharmacies (2011)                        510\                                                                      \~700\                                                                                                     \~900\
                                                               One pharmacy per 2627 inhabitants                                         One pharmacy per 7000 inhabitants                                                                          One pharmacy per 10.500 inhabitants

  Ownership of community pharmacies                            Private, \~85% in pharmacy chains or working in cooperation with chains   Private, in pharmacy chains or working in cooperation with chains (32 public sector hospital pharmacies)   At the time of the study all pharmacies were owned by the government and part of the National corporation of Swedish Pharmacies

  Computer software used at community pharmacies               2-3 different types, available for not only chain pharmacies              All pharmacies use FarmaPro program                                                                        At the time of the study all pharmacies used the same soft-ware

  E-prescription                                               Since 2010                                                                Since 2011                                                                                                 Since 1983; \>85 % of all new prescriptions at the time of the study

  Telephone and fax prescriptions                              No                                                                        Yes                                                                                                        Yes

  Printed prescriptions                                        Yes, primary and secondary care                                           Yes, primary and secondary care                                                                            Yes

  Handwritten prescriptions                                    Yes, to some extent in secondary care                                     Yes                                                                                                        Yes

  Legal prescription form                                      Yes                                                                       Yes                                                                                                        Yes

  Use of electronic medical record of patient by prescriber    Yes                                                                       Yes                                                                                                        Yes

  Access to electronic medical record of patient at pharmacy   No                                                                        No                                                                                                         No
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The objective of the study was to evaluate the feasibility of a generic instrument to document prescription problems requiring contact with prescriber before dispensing. The study was organized: (1) by countries: Estonia, Norway and Sweden; (2) by type of prescriptions: handwritten prescriptions, printouts of prescriptions in the electronic medical record and electronically transmitted prescription to pharmacies and (3) by recording method - self-completed by pharmacists or recording by independent observers.

Methods
=======

In Norway the protocol was self-completed by dispensing pharmacists at 9 community pharmacies located in the western and eastern regions of the country. The study was undertaken over the course of 5 weeks, 25 weekdays per pharmacy in September and October 2004.[@B21]

In Estonia, the protocol was completed by independent observers (trained pharmacy students). Data were collected over a period of 6 weeks and 30 weekdays per pharmacy in January, July and September 2006. Four community pharmacies located near GP centres or in ambulatory clinics in 3 larger cities participated in the study.[@B22]

In Sweden the protocol was used in a study with 7 community pharmacies in large cities in the middle and northern part of country.[@B17] The protocol was completed by independent observers (trained pharmacy students) over the course of three consecutive weeks, 15 weekdays, per pharmacy from February 2007 to February 2008.

The protocol and form, originally developed in the USA, has been translated and adapted to the Scandinavian context by one of the authors (SH).[@B21],[@B23] The Estonian translation was piloted for 3 days at one community pharmacies that later participated in the study. The Swedish version was piloted by independent observers in a pre-study at 4 community pharmacies for 2 weeks per pharmacy. One author in each country scrutinised the protocols. Classification problems and irregularities in classification were discussed with the observers for consensus and consistency.

Prescriptions on medications to humans with errors, ambiguities or other problems, where the pharmacist judged it necessary to contact the prescriber for clarification, correction, completion or change before dispensing were included in the study. All attempts to contact the prescribers were recorded whether or not they resulted in an actual contact.

The prescription problems were categorised as:

1.  Administrative errors -- technical errors concerning information about the prescriber or the patient, missing or erroneous date, reimbursement issues;

2.  Problems with clinical significance -- inappropriate medication or indication; inappropriate strength, dose or administration form of medication; adverse drug reactions or drug-drug interactions; insufficient information concerning use of medication (instruction for use, quantity, duration of treatment);

3.  Other problem -- mostly those involving delivery -- prescription of an unlicensed medication; unavailability of the licensed medication on the market, out of stock at the wholesaler or at the pharmacy.

Categorisation of the prescription problems was initially performed by one of the authors (AE) and was reviewed and discussed with the other authors (SH) and (DV).

The initial analysis of the data was performed in a spread sheet (Microsoft Excel®). For statistical analysis program Statistical Package for Social Sciences (SPSS, Version 11.0, Chicago, IL) was used. Two-way Anova was used to calculate the probability of incidence of different types of errors with different type of prescription and context (Estonia, Norway, Sweden). Type of prescription error was used as dependent variable, prescription type and country were used as fixed factors. Post hoc tests were used to perform detailed analysis for prescription error, country and prescription type. The statistical significance level was set to P≤0.05.

Results
=======

For 732 (0.51%) of all dispensed prescriptions, 194 (1.47%) in Estonia, 311 (0.45%) in Norway and 229 (0.38%) in Sweden, the pharmacists judged it necessary to contact the prescriber for clarification before dispensing.

About 80% of the problem prescriptions were new prescriptions. There was statistically significant difference (p\<0.001) in the types of prescriptions requiring contact with prescriber between Estonia, Norway and Sweden. Handwritten prescriptions constituted 73.2% in Estonia, 10.9% in Norway and 9.2% in Sweden. In Norway, the majority of the problem prescriptions were printouts of prescriptions in the electronic medical record and in Sweden more than half of the prescriptions were electronically transmitted prescriptions to pharmacies ([Table 2](#T2){ref-type="table"}).

###### 

Description of prescriptions that required contact with the prescriber before dispensing

                                                                                                                                                                              Estonia (n=4)   Norway (n=9)   Sweden (n=7)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- -------------- --------------
  Dispensed prescriptions                                                                                                                                                     13,221          69,315         59,901
  Contact with prescriber before dispensing                                                                                                                                   194 (1.47%)     311 (0.45%)    229 (0.38%)
  Handwritten prescriptions                                                                                                                                                   142 (73.2%)     31 (10.0%)     17 (7.4%)
  Printouts of prescriptions written in the electronic medical record-printouts                                                                                               52 (26.8%)      273 (87.8%)    77 (33.6%)
  Electronically transmitted prescription                                                                                                                                     \-              \-             128 (55.9%)
  Prescription is not classified as handwritten prescriptions, printouts of prescriptions written in the electronic medical record, electronically transmitted prescription                   6 (1.9%)       7 (3.1%)

There were statistically significant differences between the countries for problems with selection of medication or incorrect indication \[F(2)=7.979; p\<0.001), and dosage schedule (F(2)=5.333; p\<0.001). For problems with incorrect medication or indication, the post hoc analysis revealed statistically significant differences between a) Estonia and Norway, and b) Estonia and Sweden (p\<0.01). There were also differences for \'dosage schedule problems\' between a) Estonia and Sweden, and b) Norway and Sweden. Although not statistically significant, there was a trend that clinically important errors were more common with electronically transmitted prescriptions compared with printouts of prescriptions in the electronic medical record printouts and handwritten prescriptions.

Estonia had the highest incidence of administrative errors due to the high proportion of handwritten prescriptions ([Table 3](#T3){ref-type="table"}). Statistically significant correlations were observed between missing information about the patient and a) prescription type (F(2)=6.326; p\<0.01) and b) country (F(2)=7.679; p\<0.01). Post hoc analysis demonstrated statistically significant differences for handwritten prescriptions, printouts of prescriptions in the electronic medical record and electronically transmitted prescriptions to pharmacies (p\<0.001), between a) Estonia and Norway (p=0.01) and b) Estonia and Sweden (p\<0.001).

###### 

Distribution of prescription errors by country (number of problem prescriptions)

  -----------------------------------------------------------------------------------------------------------------------------------------------
                                         Estonia (n=194)   Norway (n=311)   Sweden (n=229)   Two-way Anova                             
  -------------------------------------- ----------------- ---------------- ---------------- --------------- ----- ------ ------------ ----------
  Incorrect medication                   73                38.7             131              42.1            106   46.3                 

  Incorrect medication/indication        6                 3.1              42               13.5            55    24.0   F(2)=7.979   p\<0.001

  Incorrect strength of medication       32                16.5             35               11.3            13    5.7    F(2)=1.485   NS

  Incorrect administration form          10                5.2              10               3.2             20    8.7    F(2)=0.327   NS

  Treatment period/number of doses       17                8.8              38               12.2            13    5.7    F(2)=0.785   NS

  Contraindication                       2                 1.0              2                0.6             2     0.9    NA           NA

  Drug-drug interaction                  5                 2.6              4                1.3             3     1.3    NA           NA

  ADR/toxicity                           3                 1.5              \-               \-              \-    \-     NA           NA

  Delivery problems                      29                14.9             43               13.8            45    19.7   NA           NS

  Schedule/instructions for use          24                12.4             76               24.4            65    28.4                 

  Schedule                               13                6.7              39               12.5            60    26.2   F(2)=5.333   p\<0.01

  Instructions for use                   11                5.7              37               11.9            5     2.2    F(2)=2.864   NS

  Administrative errors                  96                49.5             121              38.9            21    9.2                  

  Patient                                30                15.5             19               6.1             2     0.9    F(2)=6.326   p\<0.01

  Wrong patient                          \-                \-               3                1.0             1     0.4    NA           NA

  Prescriber                             42                21.6             44               14.1            2     0.9    F(2)=7.679   p\<0.01

  Reimbursement of price of medication   24                12.4             55               17.7            16    7.0    F(2)=0.375   NS

  Total (errors)                         222                                371                              237                        

  Errors per prescription                1.1                                1.1                              1.0                        

  NA - not applicable\                                                                                                                 
  NS - not significant                                                                                                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------

Delivery problems were common in all three countries ([Table 3](#T3){ref-type="table"}).

There was statistically significant difference in successful contact of the pharmacists with prescriber in Estonia, Norway and Sweden (p\<0.05). The pharmacist did not succeed to reach the prescriber for 15 (7.8%) of the cases in Estonia, 71 (22.8%) in Norway and 63 (27.5%) in Sweden. In Estonia the most common outcome was \"no dispensing of the drug\" (4 cases) or \"dispensed as prescribed\" (5 cases). In Sweden, contact with another physician, with a nurse at the ward/surgery, with a secretary or making a different intervention constituted 1/4th each of these instances. In Norway, for 39 (54.9%) cases the prescription was changed and dispensed and the prescriber was contacted afterwards.

When the pharmacists contacted the prescriber, the pharmacist\'s suggestions were approved by the prescriber in 68.8% of the cases in Estonia, 69.1% in Norway and 67.0% in Sweden.

Discussion
==========

Several independent studies using different protocols have documented the detection of prescription problems by community pharmacists and their interventions to solve them.[@B5],[@B7],[@B8],[@B9],[@B11] As far as the authors of this article know this is the first international study using a generic study instrument to identify the patterns and magnitude of prescription errors in different contexts.

The study instrument was comprehensive with respect to recording different types of prescription errors or omissions (including adaptation to record new problems and errors associated with printouts of prescriptions written in the electronic medical record and electronically transmitted prescriptions), actions taken by the pharmacist and the outcome. The study instrument in this study could be used in everyday practice at community pharmacies for self-completion of recording of prescription problems or for research purposes to evaluate more complex questions.

The pattern of prescription errors with potential clinical hazards varied by country, but appeared to be similar with all types of prescriptions. However this is not confirmed by other studies.[@B14],[@B24],[@B25]

In the current study, only few cases of drug-drug interactions were detected, contrasting the results in studies using prescription databases.[@B26],[@B27] The difference may to some extent depend on that in Estonia and Sweden pharmacists at the time of the study had access to patients\' pharmacy record for identification of possible interactions between the new prescription medications and those dispensed previously. In Belgium, pharmacists could access patients\' records and this increased their professional independence in handling prescription errors, a result supported by the other studies.[@B28]

The incidence of administrative errors was directly associated with how the prescriptions were generated similar to the findings in other studies.[@B29],[@B30] In Estonia and Norway, electronically transmitted prescription had not been introduced at the time of the study, and the number of administrative errors was higher than in Sweden, with a high proportion of electronically transmitted prescription.

The generic instrument used has not been validated against any standard as the authors did not find any standards to use. However, the classification was validated by different means in consensus discussions in all three countries.

It should be emphasized that problems in the study only represent a fraction of all prescription problems. The current selection of problem prescriptions can be explained by desire to focus on problems in the content of the prescription, rather than administrative or technical errors.

It was not possible to calculate the relative incidence of problem prescriptions for handwritten prescriptions, printouts of prescriptions written in the electronic medical record-printouts and electronically transmitted prescriptions, as dispensing data are not available for the different prescription types. However, the classification of different prescription types was undertaken only for the purposes of the current study; by the study observers in Estonia for all problem prescriptions identified during the study period and in Norway and Sweden for problem prescription requiring contact with the prescriber.

Moreover, the data collection and the protocol was used in different modes - self-completed in Norway and independent observers in Estonia and Sweden - why the results may not be totally comparable. However, the differences in the number of recorded prescription problems are associated with prescription type rather than recording method. It is also reasonable to assume that adherence to the self-reporting protocol decreases in periods of high work-load compared to studies performed by an independent observer.[@B31] Moreover, the participating pharmacies were not randomly selected and may thus not be representative for all pharmacies within each country.

The studies in three countries were also undertaken in different years. However, it was more important to find a period in which no major reforms were taking place in the community pharmacy sector or drug prescribing system than to undertake parallel studies.

The objective was to evaluate the feasibility of using a generic instrument for documentation and classification of problem prescriptions in different contexts, not to compare the incidence of prescription errors. The presented results illustrate more the feasibility of the generic protocol to document and classify prescription problems. The presented data should not be generalized to problem incidence in the individual countries.

Conclusions
===========

The generic protocol was shown to be appropriate and feasible to document prescription problems in different contexts involving country, prescription type, the pattern and number of prescription problems and recording methods. The study revealed differences in the pattern and number of prescription problems in Estonia, Norway and Sweden. The number of problem prescriptions was three times higher in Estonia compared with Norway and Sweden, mainly because of the high frequency of handwritten prescriptions. Electronically transmitted prescription to pharmacies may reduce the total number of prescribing errors -- e.g. administrative errors as well as errors of clinical importance, but may also introduce new clinically important errors, such as selection of inappropriate medication.

Some aspects of health care system organization (type of prescription, pharmacists\' access to patients\' medical record) may have direct impact on the content, number and handling of prescription problems. Access to the patients\' medical record could increase the detection of possible adverse drug reactions and drug-drug interactions.
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